Mertiatide

Platelet glycoproteinⅡb/Ⅲa receptor antagonist:eptifibatide;

血小板糖蛋白Ⅱb/Ⅲa受体拮抗药依替巴肽

Eptifibatide or tirofiban was predominantly initiated in the catheter laboratory before the intervention.

目的探讨依替巴肽与替罗非班在急性冠状动脉综合征(ACS)介入治疗中的临床疗效和安全性。